Drug recall · October 29, 2014
Bystolic recall
Why: Failed Dissolution Specification; at the 6-month stability time point
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Bystolic (nebivolol) tablets, 20 mg/tablet, packaged as 7 tablets/bottle/carton, and 12 bottles/trays, Professional Sample, Rx only, Forest Pharmaceuticals, Inc., St. Louis, MO. --- NDC 0456-1420-07
- Lots / codes
Lot A369286, exp. date 31 Jan 2016
- Quantity
- 94,584 cartons
- Company
- Forest Pharmaceuticals Inc, Earth City, MO
- Distribution
- Nationwide including Puerto Rico.
- Initiated
- September 26, 2014 · Voluntary: Firm initiated
- Classified
- October 17, 2014
- Reported
- October 29, 2014
- Ended
- March 29, 2017
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Bystolic
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.